Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

New Obesity Treatment Launched

Rimonabant (Acomplia®) has been launched in the UK. It is licensed as an adjunct to diet and exercise in patients with a BMI > 30kg/m2 or a BMI > 27 kg/m2 and associated risk factors such as Type II Diabetes.

The full Summary of Product Characteristics is available online. It should be noted that this drug is black triangle and all suspected adverse reactions should be reported.

It is expected that there will be a high level of media interest, especially as this drug is a cannabinoid-1 (CB1) receptor blocker. At this time there are no comparative studies comparing this new treatment with the currently available treatment options.

The costs of the available treatments are:

  • Orlistat (Xenical®) - £39.51 per month
  • Sibutramine (Reductil®) - £41.29 to £45.14 per month
  • Rimonobant (Acomplia®) - £55.20 per month

Action: Based on the lack of comparative studies and the higher acquisition cost this drug provides a fourth-line choice in patients who fail to respond to diet and exercise followed by both existing treatment options.

Share 'New Obesity Treatment Launched' on Email Share 'New Obesity Treatment Launched' on Delicious Share 'New Obesity Treatment Launched' on Digg Share 'New Obesity Treatment Launched' on Facebook Share 'New Obesity Treatment Launched' on Google+ Share 'New Obesity Treatment Launched' on reddit Share 'New Obesity Treatment Launched' on StumbleUpon Share 'New Obesity Treatment Launched' on Twitter

atomic-wealth

One Comments to “New Obesity Treatment Launched”

  1. […] previously discussed, rimonobant occupies a last line option for treatment of obesity as an adjunct to diet and […]

    Pingback by FDA Reject Rimonabant | Prescribing Advice For GPs — June 14, 2007 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,658 spam comments.

atomic-wealth
fond-illness
summer